See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Vatican
Ukraine War
Volodymyr Zelenskyy
Olaf Scholz
Donald Trump
Elon Musk
Israel-Hamas Conflict
Vladimir Putin
Premier League
Baseball
Tennis
Published • loading... • Updated

Mondelēz Appoints Reckitt Exec To Lead Operations In Europe

Summary by kamcity.com
Mondelēz International, the owner of brands such as Cadbury and Oreo, has announced the appointment of Volker Kuhn as Executive VP and President of its business in Europe. He will take on the role from 1 April 2025, replacing Vinzenz (more…) The post Mondelēz Appoints Reckitt Exec To Lead Operations In Europe appeared first on KamCity.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
kamcity.comkamcity.com

Mondelēz Appoints Reckitt Exec To Lead Operations In Europe

Mondelēz International, the owner of brands such as Cadbury and Oreo, has announced the appointment of Volker Kuhn as Executive VP and President of its business in Europe. He will take on the role from 1 April 2025, replacing Vinzenz (more…) The post Mondelēz Appoints Reckitt Exec To Lead Operations In Europe appeared first on KamCity.

Read Full Article
Investment MonitorInvestment Monitor

Reckitt bolsters US presence with new Wilson OTC facility

The new facility will help to boost Reckitt's production of Mucinex cold and flu relief to meet increased demand in the US.

Read Full Article
CDR – Chain Drug ReviewCDR – Chain Drug Review

Reckitt opens new state-of-the-art North Carolina factory will produce Mucinex

SLOUGH, UK –  Reckitt Benckiser Group Plc announces the acquisition of a pharmaceutical site in Wilson, N.C. that will expand its U.S. manufacturing footprint and allow it to produce Mucinex tablets and liquids to meet increased consumer demand for cold and flu symptom relief in the United States. Reckitt is investing £155 million ($200 million) in the site to establish a state-of-the-art manufacturing facility, which will ensure a more resilie…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CDR – Chain Drug Review broke the news in on Wednesday, December 4, 2024.
Sources are mostly out of (0)

Similar News Topics

Wilson, North Carolina

Wilson, North Carolina

News
For You
Search
BlindspotLocal